Vyome Holdings, Inc. (HIND)
1.45
-0.06
(-3.97%)
USD |
NASDAQ |
Nov 19, 16:00
1.41
-0.04
(-2.76%)
After-Hours: 20:00
Vyome Holdings Enterprise Value : 4.791M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 4.791M |
| November 18, 2026 | 5.212M |
| November 17, 2026 | 5.458M |
| November 16, 2026 | 5.353M |
| November 13, 2026 | 5.704M |
| November 12, 2026 | 6.055M |
| November 11, 2026 | 5.633M |
| November 10, 2026 | 5.423M |
| November 09, 2026 | 5.774M |
| November 06, 2026 | 5.704M |
| November 05, 2026 | 6.055M |
| November 04, 2026 | 6.798M |
| November 03, 2026 | 7.037M |
| November 02, 2026 | 6.967M |
| October 30, 2026 | 7.248M |
| October 29, 2026 | 6.897M |
| October 28, 2026 | 6.686M |
| October 27, 2026 | 6.546M |
| October 26, 2026 | 6.616M |
| October 23, 2026 | 7.178M |
| October 22, 2026 | 7.248M |
| October 21, 2026 | 7.528M |
| October 20, 2026 | 7.528M |
| October 19, 2026 | 7.528M |
| October 16, 2026 | 7.739M |
| Date | Value |
|---|---|
| October 15, 2026 | 8.020M |
| October 14, 2026 | 8.160M |
| October 13, 2026 | 8.441M |
| October 12, 2026 | 8.722M |
| October 09, 2026 | 9.283M |
| October 08, 2026 | 8.862M |
| October 07, 2026 | 8.932M |
| October 06, 2026 | 9.072M |
| October 05, 2026 | 8.160M |
| October 02, 2026 | 8.020M |
| October 01, 2026 | 8.090M |
| September 30, 2026 | 8.160M |
| September 29, 2026 | 7.570M |
| September 28, 2026 | 7.641M |
| September 25, 2026 | 7.711M |
| September 24, 2026 | 7.851M |
| September 23, 2026 | 7.500M |
| September 22, 2026 | 7.079M |
| September 21, 2026 | 6.939M |
| September 18, 2026 | 8.132M |
| September 17, 2026 | 7.149M |
| September 16, 2026 | 7.079M |
| September 15, 2026 | 7.500M |
| September 14, 2026 | 7.851M |
| September 11, 2026 | 7.851M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cardiac Biotech Solutions, Inc. | 6.406M |
| Anika Therapeutics, Inc. | 159.06M |
| Enovis Corp. | 2.845B |
| Edwards Lifesciences Corp. | 55.95B |
| Perspective Therapeutics, Inc. | -108.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9303M |
| Revenue (Quarterly) | 0.058M |
| Total Expenses (Quarterly) | 0.9434M |
| EPS Diluted (Quarterly) | -0.1262 |
| Gross Profit Margin (Quarterly) | 41.55% |
| Profit Margin (Quarterly) | -1.60K% |
| Earnings Yield | -39.64% |
| Normalized Earnings Yield | -39.64 |